株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の医療大麻の市場 - 用途別・投与経路別・流通チャネル別・地域別:産業分析、将来展望、成長可能性、価格動向、企業別市場シェア、将来予測

U.S. Medical Marijuana Market Size By Application, By Route of Administration, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

発行 Global Market Insights Inc. 商品コード 729956
出版日 ページ情報 英文 150 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.77円で換算しております。
米国の医療大麻の市場 - 用途別・投与経路別・流通チャネル別・地域別:産業分析、将来展望、成長可能性、価格動向、企業別市場シェア、将来予測 U.S. Medical Marijuana Market Size By Application, By Route of Administration, By Distribution Channel, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024
出版日: 2018年09月03日 ページ情報: 英文 150 Pages
概要

当レポートでは、米国国内の医療用マリファナの市場について分析し、業界の基本構造や求心力、医療大麻の法令・規制環境、主な市場促進・抑制要因、用途別・投与経路別・流通チャネル別・地域別の市場動向見通し (過去5年間・今後7年間分)、主要企業のプロファイル・業績・戦略などを調査しております。

第1章 分析手法と市場範囲

第2章 エグゼクティブ・サマリー

第3章 米国の医療大麻産業の分析

  • イントロダクション
  • 産業情勢 (通算12年間分)
  • 業界への影響要因
    • 成長促進要因
    • 業界の陥穽と課題
  • 成長可能性の分析
    • 用途別
    • 投与経路別
    • 流通チャネル別
  • ポーターのファイブフォース分析
  • 競争環境
    • 事業概要
    • 市場収益額の分析
    • 製品環境
    • 企業戦略の一覧
  • PESTEL分析
  • バリューチェーンの分析
  • 医療用マリファナ流通の法的要件
  • 規制環境

第4章 米国の医療大麻市場:用途別

  • 用途別の市場シェア (最新値・予測値)
  • 疼痛管理
    • 市場規模の推定値・予測値 (通算12年間分)
    • 神経因性頭痛
    • がん性頭痛
    • その他
  • 筋痙攣
  • 悪心
  • 拒食症
  • 発作
  • その他

第5章 米国の医療大麻市場:投与経路別

  • 投与経路別の市場シェア (最新値・予測値)
  • 吸入投与
  • 経口投与
  • 局所投与

第6章 米国の医療大麻市場:流通チャネル別

  • 流通チャネル別の市場シェア (最新値・予測値)
  • 病院薬局
  • オンライン

第7章 米国の医療大麻市場:地域別

  • 地域別の市場シェア (最新値・予測値)
  • 北東部 (コネチカット、メイン、マサチューセッツ、ニューハンプシャー、ロードアイランド、バーモント、ニュージャージー、ニューヨーク、ペンシルベニア)
  • 東北中部 (イリノイ、ミシガン)
  • 南部大西洋岸 (デラウェア、フロリダ、メリーランド、ワシントンD.C.)
  • 西北中部 (ミネソタ)
  • 太平洋岸 (アラスカ、カリフォルニア、ハワイ、オレゴン、ワシントン)
  • 山岳地帯 (アリゾナ、コロラド、ネバダ、ニューメキシコ、モンタナ)

第8章 企業プロファイル

  • Canopy Growth
    • 事業概要
    • 財務データ
    • 製品環境
    • 戦略展望
    • SWOT分析
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • GW Pharmaceuticals
  • mCig
  • Medical Marijuana, Inc.
  • United Cannabis
  • The Supreme Cannabis Company
  • Tilray
  • Emerald Health Therapeutics
  • Lexaria Corporation
  • Cannabis Sativa, Inc.
  • Insys Therapeutics, Inc.
  • Corbus Pharmaceuticals
  • GBSciences, Inc.
  • The Cronos Group
図表

Data Tables

  • TABLE 1. U.S. medical marijuana industry 360 0 synopsis, 2013 - 2024
  • TABLE 2. U.S. medical marijuana market, 2013 - 2024, (USD Million)
  • TABLE 3. U.S. medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 4. U.S. medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 5. U.S. medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 6. U.S. medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 7. U.S. medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 8. U.S. medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 9. U.S. medical marijuana market by region, 2013 - 2017 (USD Million)
  • TABLE 10. U.S. medical marijuana market by region, 2018 - 2024 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Pain management market by region, 2013 - 2017 (USD Million)
  • TABLE 13. Pain management market by region, 2018 - 2024 (USD Million)
  • TABLE 14. Neuropathic pain market by region, 2013 - 2017 (USD Million)
  • TABLE 15. Neuropathic pain market by region, 2018 - 2024 (USD Million)
  • TABLE 16. Cancer pain market by region, 2013 - 2017 (USD Million)
  • TABLE 17. Cancer pain market by region, 2018 - 2024 (USD Million)
  • TABLE 18. Others market by region, 2013 - 2017 (USD Million)
  • TABLE 19. Others market by region, 2018 - 2024 (USD Million)
  • TABLE 20. Muscle spasms market by region, 2013 - 2017 (USD Million)
  • TABLE 21. Muscle spasms market by region, 2018 - 2024 (USD Million)
  • TABLE 22. Nausea market by region, 2013 - 2017 (USD Million)
  • TABLE 23. Nausea market by region, 2013 - 2017 (USD Million)
  • TABLE 24. Anorexia market by region, 2013 - 2017 (USD Million)
  • TABLE 25. Anorexia market by region, 2018 - 2024 (USD Million)
  • TABLE 26. Seizures market by region, 2013 - 2017 (USD Million)
  • TABLE 27. Seizures market by region, 2018 - 2024 (USD Million)
  • TABLE 28. Others market by region, 2013 - 2017 (USD Million)
  • TABLE 29. Others market by region, 2018 - 2024 (USD Million)
  • TABLE 30. Inhalation market by region, 2013 - 2017 (USD Million)
  • TABLE 31. Inhalation market by region, 2018 - 2024 (USD Million)
  • TABLE 32. Oral market by region, 2013 - 2017 (USD Million)
  • TABLE 33. Oral market by region, 2018 - 2024 (USD Million)
  • TABLE 34. Topical market by region, 2013 - 2017 (USD Million)
  • TABLE 35. Topical market by region, 2018 - 2024 (USD Million)
  • TABLE 36. Dispensaries market by region, 2013 - 2017 (USD Million)
  • TABLE 37. Dispensaries market by region, 2018 - 2024 (USD Million)
  • TABLE 38. Online market by region, 2013 - 2017 (USD Million)
  • TABLE 39. Online market by region, 2018 - 2024 (USD Million)
  • TABLE 40. East North Central medical marijuana market, by state, 2013 - 2017, (USD Million)
  • TABLE 41. East North Central medical marijuana market, by state, 2018 - 2024 (USD Million)
  • TABLE 42. East North Central medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 43. East North Central medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 44. East North Central medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 45. East North Central medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 46. East North Central medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 47. East North Central medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 48. Connecticut medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 49. Connecticut medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 50. Connecticut medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 51. Connecticut medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 52. Connecticut medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 53. Connecticut medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 54. Maine medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 55. Maine medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 56. Maine medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 57. Maine medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 58. Maine medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 59. Maine medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 60. Massachusetts medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 61. Massachusetts medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 62. Massachusetts medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 63. Massachusetts medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 64. Massachusetts medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 65. Massachusetts medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 66. New Hampshire medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 67. New Hampshire medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 68. New Hampshire medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 69. New Hampshire medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 70. New Hampshire medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 71. New Hampshire medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 72. Rhode Island medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 73. Rhode Island medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 74. Rhode Island medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 75. Rhode Island medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 76. Rhode Island medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 77. Rhode Island medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 78. Vermont medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 79. Vermont medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 80. Vermont medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 81. Vermont medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 82. Vermont medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 83. Vermont medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 84. New Jersey medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 85. New Jersey medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 86. New Jersey medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 87. New Jersey medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 88. New Jersey medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 89. New Jersey medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 90. New York medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 91. New York medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 92. New York medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 93. New York medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 94. New York medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 95. New York medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 96. Pennsylvania medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 97. Pennsylvania medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 98. Pennsylvania medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 99. Pennsylvania medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 100. Pennsylvania medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 101. Pennsylvania medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 102. East North Central medical marijuana market, by state, 2013 - 2017, (USD Million)
  • TABLE 103. East North Central medical marijuana market, by state, 2018 - 2024 (USD Million)
  • TABLE 104. East North Central medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 105. East North Central medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 106. East North Central medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 107. East North Central medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 108. East North Central medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 109. East North Central medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 110. Illinois medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 111. Illinois medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 112. Illinois medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 113. Illinois medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 114. Illinois medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 115. Illinois medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 116. Michigan medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 117. Michigan medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 118. Michigan medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 119. Michigan medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 120. Michigan medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 121. Michigan medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 122. South Atlantic medical marijuana market, by state, 2013 - 2017, (USD Million)
  • TABLE 123. South Atlantic medical marijuana market, by state, 2018 - 2024 (USD Million)
  • TABLE 124. South Atlantic medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 125. South Atlantic medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 126. South Atlantic medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 127. South Atlantic medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 128. South Atlantic medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 129. South Atlantic medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 130. Delaware medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 131. Delaware medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 132. Delaware medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 133. Delaware medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 134. Delaware medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 135. Delaware medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 136. Florida medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 137. Florida medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 138. Florida medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 139. Florida medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 140. Florida medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 141. Florida medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 142. Maryland medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 143. Maryland medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 144. Maryland medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 145. Maryland medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 146. Maryland medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 147. Maryland medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 148. Washington D.C. medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 149. Washington D.C. medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 150. Washington D.C. medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 151. Washington D.C. medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 152. Washington D.C. medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 153. Washington D.C. medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 154. West North Central medical marijuana market, by state, 2013 - 2017, (USD Million)
  • TABLE 155. West North Central medical marijuana market, by state, 2018 - 2024 (USD Million)
  • TABLE 156. West North Central medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 157. West North Central medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 158. West North Central medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 159. West North Central medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 160. West North Central medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 161. West North Central medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 162. Minnesota medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 163. Minnesota medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 164. Minnesota medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 165. Minnesota medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 166. Minnesota medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 167. Minnesota medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 168. Pacific Central medical marijuana market, by state, 2013 - 2017, (USD Million)
  • TABLE 169. Pacific Central medical marijuana market, by state, 2018 - 2024 (USD Million)
  • TABLE 170. Pacific Central medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 171. Pacific Central medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 172. Pacific Central medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 173. Pacific Central medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 174. Pacific Central medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 175. Pacific Central medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 176. Alaska medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 177. Alaska medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 178. Alaska medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 179. Alaska medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 180. Alaska medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 181. Alaska medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 182. California medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 183. California medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 184. California medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 185. California medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 186. California medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 187. California medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 188. Hawaii medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 189. Hawaii medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 190. Hawaii medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 191. Hawaii medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 192. Hawaii medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 193. Hawaii medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 194. Oregon medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 195. Oregon medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 196. Oregon medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 197. Oregon medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 198. Oregon medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 199. Oregon medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 200. Washington medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 201. Washington medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 202. Washington medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 203. Washington medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 204. Washington medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 205. Washington medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 206. Mountain States medical marijuana market, by state, 2013 - 2017, (USD Million)
  • TABLE 207. Mountain States medical marijuana market, by state, 2018 - 2024 (USD Million)
  • TABLE 208. Mountain States medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 209. Mountain States medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 210. Mountain States medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 211. Mountain States medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 212. Mountain States medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 213. Mountain States medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 214. Arizona medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 215. Arizona medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 216. Arizona medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 217. Arizona medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 218. Arizona medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 219. Arizona medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 220. Colorado medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 221. Colorado medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 222. Colorado medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 223. Colorado medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 224. Colorado medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 225. Colorado medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 226. Nevada medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 227. Nevada medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 228. Nevada medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 229. Nevada medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 230. Nevada medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 231. Nevada medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 232. New Mexico medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 233. New Mexico medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 234. New Mexico medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 235. New Mexico medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 236. New Mexico medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 237. New Mexico medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)
  • TABLE 238. Montana medical marijuana market, by application, 2013 - 2017, (USD Million)
  • TABLE 239. Montana medical marijuana market, by application, 2018 - 2024 (USD Million)
  • TABLE 240. Montana medical marijuana market, by route of administration, 2013 - 2017, (USD Million)
  • TABLE 241. Montana medical marijuana market, by route of administration, 2018 - 2024 (USD Million)
  • TABLE 242. Montana medical marijuana market, by distribution channel, 2013 - 2017, (USD Million)
  • TABLE 243. Montana medical marijuana market, by distribution channel, 2018 - 2024 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 U.S. medical marijuana market, 2013 - 2024 (USD Million)
  • FIG. 3 Growth potential analysis, by application
  • FIG. 4 Growth potential analysis, by route of administration
  • FIG. 5 Growth potential analysis, by distribution channel
  • FIG. 6 Porter's analysis
  • FIG. 7 Strategy dashboard
  • FIG. 8 PESTEL analysis
  • FIG. 9 Value chain analysis
目次
Product Code: 2890

Title:
U.S. Medical Marijuana Market Size By Application (Pain Management, Muscle Spasms, Nausea, Anorexia, Seizures, Others), By Route of Administration (Inhalation, Oral, Topical), By Distribution Channel (Dispensaries, Online), Industry Analysis Report, Regional Outlook (North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East North Central {Illinois, Michigan}, South Atlantic {Delaware, Florida, Maryland, Washington, D.C.}, West North Central {Minnesota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Nevada, New Mexico, Montana}), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024.

U.S. Medical Marijuana Market will exceed USD 8.0 billion by 2024; as per a new research report.

More than half of the U.S. states and Washington D.C. have legalized marijuana for therapeutic application. Increased number of people affected with chronic pain caused due to cancer, HIV/AIDS and neurological diseases will drive the market growth in the U.S. In addition, rigorous research and development on marijuana is also rising in the U.S., thereby opening avenues for novel products in the market.

U.S. has allowed to issue medical marijuana cards in 30 states that will enable a patient with a doctor's recommendation to obtain and possess marijuana for therapeutic use. There has been increase in the number of doctors in the U.S. recommending medical marijuana to patients as a part of their overall plan of treatment due to marijuana's greater efficacy and usefulness, thereby boosting sales.

However, factors such as few adverse side effects of marijuana, lack of safety data, strict U.S. regulatory norms and difficulty in setting up marijuana business will act as major barriers in the growth of U.S. medical marijuana market.

The U.S. medical marijuana anorexia market segment is estimated to witness a CAGR of around 13.1% during the forecast period. Marijuana contains appetite stimulant, which accelerates the treatment of anorexia. In addition, anorexia is a serious, potentially life-threatening eating disorder in the U.S. that has been constantly increasing, thereby boosting the market segment growth.

The U.S. medical marijuana inhalation market segment is estimated to grow at 13.4% CAGR during the forecast period. Factors such as controlled dosage rates and better absorption of medical marijuana into the body will drive the inhalation route of administration market segment. Moreover, the U.S. population prefers to inhale medical marijuana owing to its better perceiving rate with high peak concentrations.

U.S. online medical marijuana market segment is forecasted to expand at a CAGR of 13.9% during 2018-2024. Factors such as vast product portfolio, convenience, and competitive costs will boost the growth of online medical marijuana market segment. Also, online distribution channel has an effective customer service that will propel the market revenue of this segment.

The U.S. Pacific Central medical marijuana market was valued at around USD 2,085.9 million in 2017. California was the first state to legalize medical marijuana way back in 1996. Other states such as Alaska, Oregon and Washington also headed in the same pathway and got the approval for medical marijuana use in 1998. All these factors are responsible for the market growth in U.S. Pacific Central.

Some of the prominent industry players in U.S. medical marijuana market are Canopy Growth, Aurora Cannabis, Inc., Medical Marijuana, Inc., GW Pharmaceuticals, Aphria, Inc., Tilray, Emerald Health Therapeutics, and United Cannabis., among others. Increasing mergers and acquisition, and rigorous research and development activities performed by these companies are resulting into new and innovative marijuana products in the U.S. market.

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
  • 1.2. Market definitions
  • 1.3. Forecast parameters
  • 1.4. Data sources
    • 1.4.1. Secondary
      • 1.4.1.1. Paid sources
      • 1.4.1.2. Unpaid sources
    • 1.4.2. Primary

Chapter 2. Executive Summary

  • 2.1. U.S. Medical marijuana industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Application trends
    • 2.1.3. Route of administration trends
    • 2.1.4. Distribution channel trends
    • 2.1.5. Regional trends

Chapter 3. U.S. Medical Marijuana Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry impact forces
    • 3.3.1. Growth drivers
      • 3.3.1.1. Increasing application of marijuana for a myriad of medical conditions and symptoms
      • 3.3.1.2. Growing demand for medical marijuana legalization in the U.S.
      • 3.3.1.3. Rising number of R&D and clinical trial activities
    • 3.3.2. Industry pitfalls & challenges
      • 3.3.2.1. Few side effects might hinder the market growth
      • 3.3.2.2. Difficulty in medical marijuana business banking
  • 3.4. Growth potential analysis
    • 3.4.1. By application
    • 3.4.2. By route of administration
    • 3.4.3. By distribution channel
  • 3.5. Porter's analysis
  • 3.6. Competitive landscape, 2017
    • 3.6.1. Business overview
    • 3.6.2. Revenue analysis
    • 3.6.3. Product landscape
    • 3.6.4. Strategy dashboard
  • 3.7. PESTEL analysis
  • 3.8. Value chain analysis
  • 3.9. Legal Requirement for Distribution of Medical Marijuana
  • 3.10. Regulatory Landscape

Chapter 4. U.S. Medical Marijuana Market, By Application

  • 4.1. U.S. medical marijuana market share, by application, 2017 & 2024
  • 4.2. Pain Management
    • 4.2.1. Market estimates and forecast, by region, 2013 - 2024
    • 4.2.2. Neuropathic Pain
      • 4.2.2.1. Market estimates and forecast, by region, 2013 - 2024
    • 4.2.3. Cancer Pain
      • 4.2.3.1. Market estimates and forecast, by region, 2013 - 2024
    • 4.2.4. Others
      • 4.2.4.1. Market estimates and forecast, by region, 2013 - 2024
  • 4.3. Muscle Spasms
    • 4.3.1. Market estimates and forecast, by region, 2013 - 2024
  • 4.4. Nausea
    • 4.4.1. Market estimates and forecast, by region, 2013 - 2024
  • 4.5. Anorexia
    • 4.5.1. Market estimates and forecast, by region, 2013 - 2024
  • 4.6. Seizures
    • 4.6.1. Market estimates and forecast, by region, 2013 - 2024
  • 4.7. Others
    • 4.7.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 5. U.S. Medical marijuana Market, By Route of Administration

  • 5.1. U.S. medical marijuana market share, by route of administration, 2017 & 2024
  • 5.2. Inhalation
    • 5.2.1. Market estimates and forecast, by region, 2013 - 2024
  • 5.3. Oral
    • 5.3.1. Market estimates and forecast, by region, 2013 - 2024
  • 5.4. Topical
    • 5.4.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 6. U.S. Medical marijuana Market, By Distribution Channel

  • 6.1. Global medical marijuana market share, by distribution channel, 2017 & 2024
  • 6.2. Dispensaries
    • 6.2.1. Market estimates and forecast, by region, 2013 - 2024
  • 6.3. Online
    • 6.3.1. Market estimates and forecast, by region, 2013 - 2024

Chapter 7. U.S. Medical marijuana Market, By Region

  • 7.1. U.S. medical marijuana market share, by region, 2017 & 2024
  • 7.2. North Central
    • 7.2.1. Market estimates and forecast, by state, 2013 - 2024
    • 7.2.2. Market estimates and forecast, by application, 2013 - 2024
      • 7.2.2.1. Market estimates and forecast, by pain management, 2013 - 2024
    • 7.2.3. Market estimates and forecast, by route of administration, 2013 - 2024
    • 7.2.4. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.5. Connecticut
      • 7.2.5.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.6. Maine
      • 7.2.6.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.7. Massachusetts
      • 7.2.7.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.8. New Hampshire
      • 7.2.8.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.9. Rhode Island
      • 7.2.9.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.10. Vermont
      • 7.2.10.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.10.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.10.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.10.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.11. New Jersey
      • 7.2.11.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.11.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.11.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.11.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.12. New York
      • 7.2.12.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.12.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.12.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.12.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.2.13. Pennsylvania
      • 7.2.13.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.2.13.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.2.13.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.2.13.3. Market estimates and forecast, by distribution channel, 2013 - 2024
  • 7.3. East North Central
    • 7.3.1. Market estimates and forecast, by state, 2013 - 2024
    • 7.3.2. Market estimates and forecast, by application, 2013 - 2024
      • 7.3.2.1. Market estimates and forecast, by pain management, 2013 - 2024
    • 7.3.3. Market estimates and forecast, by route of administration, 2013 - 2024
    • 7.3.4. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.3.5. Illinois
      • 7.3.5.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.3.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.3.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.3.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.3.6. Michigan
      • 7.3.6.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.3.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.3.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.3.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
  • 7.4. South Atlantic
    • 7.4.1. Market estimates and forecast, by state, 2013 - 2024
    • 7.4.2. Market estimates and forecast, by application, 2013 - 2024
      • 7.4.2.1. Market estimates and forecast, by pain management, 2013 - 2024
    • 7.4.3. Market estimates and forecast, by route of administration, 2013 - 2024
    • 7.4.4. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.4.5. Delaware
      • 7.4.5.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.4.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.4.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.4.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.4.6. Florida
      • 7.4.6.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.4.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.4.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.4.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.4.7. Maryland
      • 7.4.7.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.4.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.4.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.4.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.4.8. Washington D.C.
      • 7.4.8.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.4.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.4.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.4.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
  • 7.5. West North Central
    • 7.5.1. Market estimates and forecast, by state, 2013 - 2024
    • 7.5.2. Market estimates and forecast, by application, 2013 - 2024
      • 7.5.2.1. Market estimates and forecast, by pain management, 2013 - 2024
    • 7.5.3. Market estimates and forecast, by route of administration, 2013 - 2024
    • 7.5.4. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.5.5. Minnesota
      • 7.5.5.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.5.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.5.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.5.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
  • 7.6. Pacific Central
    • 7.6.1. Market estimates and forecast, by state, 2013 - 2024
    • 7.6.2. Market estimates and forecast, by application, 2013 - 2024
      • 7.6.2.1. Market estimates and forecast, by pain management, 2013 - 2024
    • 7.6.3. Market estimates and forecast, by route of administration, 2013 - 2024
    • 7.6.4. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.6.5. Alaska
      • 7.6.5.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.6.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.6.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.6.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.6.6. California
      • 7.6.6.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.6.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.6.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.6.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.6.7. Hawaii
      • 7.6.7.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.6.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.6.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.6.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.6.8. Oregon
      • 7.6.8.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.6.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.6.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.6.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.6.9. Washington
      • 7.6.9.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.6.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.6.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.6.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024
  • 7.7. Mountain States
    • 7.7.1. Market estimates and forecast, by state, 2013 - 2024
    • 7.7.2. Market estimates and forecast, by application, 2013 - 2024
      • 7.7.2.1. Market estimates and forecast, by pain management, 2013 - 2024
    • 7.7.3. Market estimates and forecast, by route of administration, 2013 - 2024
    • 7.7.4. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.7.5. Arizona
      • 7.7.5.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.7.5.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.7.5.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.7.5.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.7.6. Colorado
      • 7.7.6.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.7.6.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.7.6.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.7.6.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.7.7. Nevada
      • 7.7.7.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.7.7.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.7.7.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.7.7.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.7.8. New Mexico
      • 7.7.8.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.7.8.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.7.8.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.7.8.3. Market estimates and forecast, by distribution channel, 2013 - 2024
    • 7.7.9. Montana
      • 7.7.9.1. Market estimates and forecast, by application, 2013 - 2024
        • 7.7.9.1.1. Market estimates and forecast, by pain management, 2013 - 2024
      • 7.7.9.2. Market estimates and forecast, by route of administration, 2013 - 2024
      • 7.7.9.3. Market estimates and forecast, by distribution channel, 2013 - 2024

Chapter 8. Company Profiles

  • 8.1. Canopy Growth
    • 8.1.1. Business overview
    • 8.1.2. Financial data
    • 8.1.3. Product landscape
    • 8.1.4. Strategic outlook
    • 8.1.5. SWOT analysis
  • 8.2. Aphria, Inc.
    • 8.2.1. Business overview
    • 8.2.2. Financial data
    • 8.2.3. Product landscape
    • 8.2.4. Strategic outlook
    • 8.2.5. SWOT analysis
  • 8.3. Aurora Cannabis, Inc.
    • 8.3.1. Business overview
    • 8.3.2. Financial data
    • 8.3.3. Product landscape
    • 8.3.4. Strategic outlook
    • 8.3.5. SWOT analysis
  • 8.4. GW Pharmaceuticals
    • 8.4.1. Business overview
    • 8.4.2. Financial data
    • 8.4.3. Product landscape
    • 8.4.4. Strategic outlook
    • 8.4.5. SWOT analysis
  • 8.5. mCig
    • 8.5.1. Business overview
    • 8.5.2. Financial data
    • 8.5.3. Product landscape
    • 8.5.4. Strategic outlook
    • 8.5.5. SWOT analysis
  • 8.6. Medical Marijuana, Inc.
    • 8.6.1. Business overview
    • 8.6.2. Financial data
    • 8.6.3. Product landscape
    • 8.6.4. Strategic outlook
    • 8.6.5. SWOT analysis
  • 8.7. United Cannabis
    • 8.7.1. Business overview
    • 8.7.2. Financial data
    • 8.7.3. Product landscape
    • 8.7.4. Strategic outlook
    • 8.7.5. SWOT analysis
  • 8.8. The Supreme Cannabis Company
    • 8.8.1. Business overview
    • 8.8.2. Financial data
    • 8.8.3. Product landscape
    • 8.8.4. Strategic outlook
    • 8.8.5. SWOT analysis
  • 8.9. Tilray
    • 8.9.1. Business overview
    • 8.9.2. Financial data
    • 8.9.3. Product landscape
    • 8.9.4. Strategic outlook
    • 8.9.5. SWOT analysis
  • 8.10. Emerald Health Therapeutics
    • 8.10.1. Business overview
    • 8.10.2. Financial data
    • 8.10.3. Product landscape
    • 8.10.4. Strategic outlook
    • 8.10.5. SWOT analysis
  • 8.11. Lexaria Corporation
    • 8.11.1. Business overview
    • 8.11.2. Financial data
    • 8.11.3. Product landscape
    • 8.11.4. Strategic outlook
    • 8.11.5. SWOT analysis
  • 8.12. Cannabis Sativa, Inc.
    • 8.12.1. Business overview
    • 8.12.2. Financial data
    • 8.12.3. Product landscape
    • 8.12.4. Strategic outlook
    • 8.12.5. SWOT analysis
  • 8.13. Insys Therapeutics, Inc.
    • 8.13.1. Business overview
    • 8.13.2. Financial data
    • 8.13.3. Product landscape
    • 8.13.4. Strategic outlook
    • 8.13.5. SWOT analysis
  • 8.14. Corbus Pharmaceuticals
    • 8.14.1. Business overview
    • 8.14.2. Financial data
    • 8.14.3. Product landscape
    • 8.14.4. Strategic outlook
    • 8.14.5. SWOT analysis
  • 8.15. GBSciences, Inc.
    • 8.15.1. Business overview
    • 8.15.2. Financial data
    • 8.15.3. Product landscape
    • 8.15.4. Strategic outlook
    • 8.15.5. SWOT analysis
  • 8.16. The Cronos Group
    • 8.16.1. Business overview
    • 8.16.2. Financial data
    • 8.16.3. Product landscape
    • 8.16.4. Strategic outlook
    • 8.16.5. SWOT analysis